ArticleAdvances in therapy2018

Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol.

Marie-Eve Muller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.